SEC Form 4 · accession 0001437749-26-023078
PUMA BIOTECHNOLOGY, INC. · PBYI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas M Hunt
Officer — See Remarks
Period of report
Jul 6, 2026
Accepted (ET)
Jul 8, 2026 · 8:19 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001401667
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 6, 2026 | S | 8,460 | $8.263 | D | 196,841 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Adoption date of referenced 10b5-1(c) sell to cover program is: 12-14-2020.
Remarks
The Reporting Person is the Senior Vice President of Regulatory Affairs of the Issuer.